Johnson & Johnson statement on COVID-19 vaccine

The safety and well-being of the people who use our products is our number one priority. We are aware of an extremely rare disorder involving people with blood clots in combination with low platelets in a small number of individuals who have received our COVID-19 vaccine.
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured Johnson & Business and Industry Source Type: news